Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2026 17:22 ET | Source: Veea Inc.

Veea Regains Full Compliance with Nasdaq Continued Listing Requirements

Veea Regains Full Compliance with Nasdaq Continued Listing Requirements
October 07, 2026 10:00 ET | Source: Zero Gravity Labs Inc

0G Doubles in Two Weeks and iAI Hit an All-Time High More Than 1,600% Above Its Launch Price

San Francisco, CA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- SINGAPORE, October 5, 2026 - The 0G token nearly doubled in the second half of September, climbing from about $0.18 on September 16 to a high of...
October 05, 2026 16:28 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

SAN CARLOS, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that it has commenced underwritten public offerings...
October 05, 2026 16:15 ET | Source: ONEOK, Inc.

ONEOK Schedules Third-Quarter 2026 Conference Call and Webcast

TULSA, Okla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- ONEOK, Inc. (NYSE: OKE) will release third-quarter 2026 earnings after the market closes on Oct. 27, 2026. Members of ONEOK’s management team will...
October 03, 2026 08:00 ET | Source: Stock Preachers

E-Brokerage Market Projected to Reach $34.6 Billion by 2034 as Record Retail Trading Volumes Lift Platforms

News Provided by Stock Preachers VANCOUVER, British Columbia, Oct. 03, 2026 (GLOBE NEWSWIRE) -- Stock Preachers News Commentary - Global Market Insights valued the e-brokerage market at $14.1...
October 02, 2026 16:05 ET | Source: Aardvark Therapeutics, Inc.

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule...
October 02, 2026 16:01 ET | Source: Carlsmed

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery...
October 02, 2026 08:30 ET | Source: Phaos Tech

Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split

SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), an advanced microscopy solutions headquartered in...
October 01, 2026 16:05 ET | Source: Akebia Therapeutics, Inc.

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
October 01, 2026 12:29 ET | Source: DAVIS COMMODITIES Ltd

Davis Commodities Limited Provides Update on OTC Markets Quotation Status

SINGAPORE, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Davis Commodities Limited (“Davis Commodities” or the “Company”) (OTC: DTCKF), an agricultural commodity trading company specializing in sugar, rice, and...